MoneyWorks4Me

IOL Chemicals & Pharmaceuticals informs about disclosure of impact of covid-19

17 Jul 2020 Evaluate

Pursuant to Regulation 30 of Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CMDl/CIR/P/2020/84 dated 20th May 2020, IOL Chemicals & Pharmaceuticals has informed about disclosure of material impact of COVID-19 pandemic under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..